Literature DB >> 22563169

Over-expression of uPA increases risk of liver injury in pAAV-HBV transfected mice.

Xiao-Jun Zhou1, Shi-Hui Sun, Peng Wang, Hong Yu, Jing-Ya Hu, Shi-Cheng Shang, Yu-Sen Zhou.   

Abstract

AIM: To investigate the relationship between over-expression of urokinase plasminogen activator (uPA) and hepatitis B virus (HBV) related liver diseases in a transgenic mouse model.
METHODS: Albumin-tetracycline reverse transcriptional activator and tetO-uPA transgenic mice were generated respectively through pronuclear injection and crossed to produce the double transgenic in-alb-uPA mice, for which doxycycline (Dox)-inducible and liver-specific over-expression of uPA can be achieved. Hydrodynamic transfection of plasmid adeno-associated virus (AAV)-1.3 HBV was performed through the tail veins of the Dox-induced in-alb-uPA mice. Expression of uPA and HBV antigens were analyzed through double-staining immunohistochemical assay. Cytokine production was detected by enzyme linked immunosorbent assay and α-fetoprotein (AFP) mRNA level was evaluated through real-time quantitative polymerase chain reaction.
RESULTS: Plasmid AAV-1.3 HBV hydrodynamic transfection in Dox-induced transgenic mice not only resulted in severe liver injury with hepatocarcinoma-like histological changes and hepatic AFP production, but also showed an increased serum level of HBV antigens and cytokines like interleukin-6 and tumor necrosis factor-α, compared with the control group.
CONCLUSION: Over-expression of uPA plays a synergistic role in the development of liver injury, inflammation and regeneration during acute HBV infection.

Entities:  

Keywords:  Albumin promoter; Hydrodynamic transfection; Liver injury; Tet-on system; Urokinase-type plasminogen activator

Mesh:

Substances:

Year:  2012        PMID: 22563169      PMCID: PMC3337564          DOI: 10.3748/wjg.v18.i16.1892

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

Review 2.  Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration.

Authors:  H A Chapman
Journal:  Curr Opin Cell Biol       Date:  1997-10       Impact factor: 8.382

3.  Silent genes in the mouse major urinary protein gene family.

Authors:  Y Shi; H J Son; K Shahan; M Rodriguez; F Costantini; E Derman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

4.  Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.

Authors:  A Kistner; M Gossen; F Zimmermann; J Jerecic; C Ullmer; H Lübbert; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

5.  An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice.

Authors:  C A Pinkert; D M Ornitz; R L Brinster; R D Palmiter
Journal:  Genes Dev       Date:  1987-05       Impact factor: 11.361

6.  Cytokine profile of viral and autoimmune chronic active hepatitis.

Authors:  A al-Wabel; M al-Janadi; S Raziuddin
Journal:  J Allergy Clin Immunol       Date:  1993-12       Impact factor: 10.793

Review 7.  Hepatitis B virus immunopathogenesis.

Authors:  F V Chisari; C Ferrari
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

8.  Developmental and liver-specific expression directed by the serum amyloid P component promoter in transgenic mice.

Authors:  X Zhao; K Araki; J Miyazaki; K Yamamura
Journal:  J Biochem       Date:  1992-06       Impact factor: 3.387

9.  Transcriptional activation by tetracyclines in mammalian cells.

Authors:  M Gossen; S Freundlieb; G Bender; G Müller; W Hillen; H Bujard
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

10.  In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.

Authors:  L Ossowski; G Clunie; M T Masucci; F Blasi
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

View more
  3 in total

1.  Celastrol delays hepatic steatosis and carcinogenesis in a rapid AKT/c-Met-transfected hepatocellular carcinoma model via suppressing fatty acid synthase expression and AKT/ERK phosphorylation.

Authors:  Junjie Hu; Xin Li; Junxuan Zhou; Cong Zhang; Guohua Zheng; Zhenpeng Qiu
Journal:  RSC Adv       Date:  2018-04-16       Impact factor: 4.036

2.  Hydrodynamic delivery of Cre protein to lineage-mark or time-stamp mouse hepatocytes in situ.

Authors:  Katherine M Sonsteng; Justin R Prigge; Emily A Talago; Ronald K June; Edward E Schmidt
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

3.  A new style of dimethylnitrosamine induced fulminant hepatitis in mice.

Authors:  Hanping Liu; Qingya Li; Hong Liu; Yuansheng Wu; Jinyang He
Journal:  Hepat Mon       Date:  2013-09-14       Impact factor: 0.660

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.